Neuren Pharmaceuticals Limited’s (NEU) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Neuren Pharmaceuticals Limited is a Sell.

Neuren Pharmaceuticals Limited’s (NEU) 20-Day exponential moving average is 13.25, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.23, making it a Buy.

Neuren Pharmaceuticals Limited’s (NEU) 50-Day exponential moving average is 13.68, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.23, making it a Sell.

Neuren Pharmaceuticals Limited (NEU) Pivot Points

Dec 18, 2024, 07:31 AM

Classic

12.60

12.87

13.06

13.33

13.52

13.79

13.98

Fibonacci

12.87

13.05

13.16

13.33

13.51

13.62

13.79

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neuren Pharmaceuticals Limited (NEU) Moving Averages

Dec 18, 2024, 07:31 AM

MA5

13.14Buy

13.18Buy

MA10

13.02Buy

13.11Buy

MA20

13.08Buy

13.25Buy

MA50

13.43Sell

13.68Sell

MA100

14.37Sell

14.78Sell

MA200

17.30Sell

17.17Sell

Neuren Pharmaceuticals Limited’s (NEU) 10-Day exponential moving average is 13.11, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.23, making it a Buy.

Neuren Pharmaceuticals Limited’s (NEU) 100-Day exponential moving average is 14.78, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.23, making it a Sell.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.23 and Neuren Pharmaceuticals Limited’s (NEU) 50-day simple moving average is 13.43, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.23 and Neuren Pharmaceuticals Limited’s (NEU) 100-day simple moving average is 14.37, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.23 and Neuren Pharmaceuticals Limited’s (NEU) 200-day simple moving average is 17.30, creating a Sell signal.

Neuren Pharmaceuticals Limited (NEU) Technical Indicators

Dec 18, 2024, 07:31 AM

RSI (14)

49.73

Neutral

STOCH (9,6)

74.80

Neutral

STOCHRSI (14)

82.34

Sell

MACD (12,26)

-0.20

Sell

ADX (14)

14.35

Buy

Williams %R

-18.71

Sell

CCI (14)

7.48

Neutral

ATR (14)

0.62

Ultimate Oscillator

51.93

Neutral

ROC

5.21

Buy

Neuren Pharmaceuticals Limited’s (NEU) Relative Strength Index (RSI) is 49.73, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NEU) Trend Strength Indicator (ADX) is 14.35, creating a Buy signal.

Neuren Pharmaceuticals Limited’s (NEU) Commodity Channel Index (CCI) is 7.48, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NEU) Price Rate of Change (ROC) is 5.21, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NEU a Buy, Hold, or Sell?

Based on NEU’s technical indicators, NEU is a Hold.

What is NEU’s RSI (14)?

NEU’s RSI (14) is 49.73, which suggests NEU is a Neutral.

What is NEU’s MACD?

NEU’s MACD is -0.20, which suggests NEU is a Sell.

What is NEU’s 5-day moving average?

NEU’s 5-day moving average is 13.14, which suggests NEU is a Buy.

What is NEU’s 20-day moving average?

NEU 20-day moving average is 13.08, which suggests NEU is a Buy.

What is NEU’s 50-day moving average?

NEU’s 50-day moving average is 13.43, which suggests NEU is a Sell.

What is NEU’s 200-day moving average?

NEU’s 200-day moving average is 17.30, which suggests NEU is a Sell.

What is NEU’s Williams % R (14)?

NEU’s Williams % R (14) is -18.71, which suggests NEU is a Sell.

What is NEU’s CCI (14)?

NEU’s CCI (14) is 7.48, which suggests NEU is a Neutral.

What is the share price of Neuren Pharmaceuticals Limited?

Neuren Pharmaceuticals Limited's share price is 13.32AU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing